Related Experiment Video

Updated: May 31, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K

What went wrong at 23andMe? Why the genetic-data giant risks collapse

Diana Kwon

    Nature
    |January 23, 2025
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    GeneticsGenomicsHealth care

    More Related Videos

    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
    11:35

    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

    Published on: August 21, 2016

    12.9K
    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.3K

    Related Experiment Videos

    Last Updated: May 31, 2025

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    11.8K
    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
    11:35

    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

    Published on: August 21, 2016

    12.9K
    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.3K

    Related Concept Videos

    Sanger Sequencing01:57

    Sanger Sequencing

    752.6K
    DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
    752.6K
    Next-generation Sequencing03:00

    Next-generation Sequencing

    87.3K
    The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
    Next-Generation Sequencing Methods
    Although all next-generation methods use different technologies, they all share a set of standard features....
    87.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    Universal gates from braiding and fusing anyons on quantum hardware.

    Nature·2026

    People use fast and flat simulation to reason about new games.

    Nature·2026

    Rising dust pollution across Europe in a changing climate.

    Nature·2026

    Ammonia pressure controls colloidal metal nitride synthesis in molten salts.

    Nature·2026

    Programming fracture resistance in metamaterials via elastic instabilities.

    Nature·2026

    Selectivity Emerges from Indiscriminate Photoreduction.

    Nature·2026

    Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

    Frontiers in endocrinology·2026

    Linking <i>SIRT1</i> gene variation and protein levels to the pathophysiology of type 2 diabetes.

    Molecular biology research communications·2026

    Pharmacogenetic analyses in people with dementia in Northeast Germany.

    Alzheimer's & dementia (Amsterdam, Netherlands)·2026

    Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis.

    Frontiers in immunology·2026

    Retraction Note: Micropropagation and assessment of genetic fidelity of <i>Dendrocalamus strictus</i> (Roxb.) nees using RAPD and ISSR markers.

    3 Biotech·2026

    Distribution of ST116 carbapenem-resistant <i>Citrobacter freundii</i> in public genomes and characterization of a triple-carbapenemase-producing strain.

    Frontiers in cellular and infection microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us